From April 1, 2024 to April 9, 2024, the company has repurchased 600,000 shares, representing 0.11% for CNY 10.48 million. With this, the company has completed the repurchase of 1,260,000 shares, representing 0.23% for CNY 29.87 million under the buyback announced on October 28, 2023.
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
14.75 CNY | -0.14% | -4.78% | -41.35% |
EPS Revisions
Quarterly revenue - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-41.35% | 1.11B | |
+40.73% | 734B | |
+32.83% | 591B | |
-6.30% | 350B | |
+15.15% | 315B | |
+4.05% | 276B | |
+15.00% | 238B | |
+9.78% | 206B | |
-5.52% | 204B | |
+6.17% | 161B |
- Stock Market
- Equities
- 300363 Stock
- News Porton Pharma Solutions Ltd.
- Tranche Update on Porton Pharma Solutions Ltd.'s Equity Buyback Plan announced on October 28, 2023.